Natalie B. Collins

Hematology | Oncology

450 Brookline Ave
Boston, MA 02215

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 32 publications

Omitting Bone Marrow Sampling in FDG-Avid Rhabdomyosarcoma With 2-[18F]FDG PET-Negative Marrow: Results From an International Retrospective Study.

Omitting Bone Marrow Sampling in FDG-Avid Rhabdomyosarcoma With 2-[18F]FDG PET-Negative Marrow: Results From an International Retrospective Study.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: August 24, 2026

Spatially resolved T cell receptor tracking reveals γδT cell localization to tumor-rich regions in high-risk neuroblastoma: A Report from the Children's Oncology Group.

Spatially resolved T cell receptor tracking reveals γδT cell localization to tumor-rich regions in high-risk neuroblastoma: A Report from the Children's Oncology Group.

Journal: medRxiv : the preprint server for health sciences

Published: June 22, 2026

Lung Adenocarcinoma and Genetic Cancer Predisposition in an Adolescent.

Lung Adenocarcinoma and Genetic Cancer Predisposition in an Adolescent.

Journal: Pediatric blood & cancer

Published: March 25, 2026

SARC031: A Phase II Trial of Selumetinib and Sirolimus for Patients with Unresectable or Metastatic Malignant Peripheral Nerve Sheath Tumors (MPNST).

SARC031: A Phase II Trial of Selumetinib and Sirolimus for Patients with Unresectable or Metastatic Malignant Peripheral Nerve Sheath Tumors (MPNST).

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: August 01, 2025

SARC031: A Phase 2 Trial of Selumetinib and Sirolimus for Patients with Unresectable or Metastatic Malignant Peripheral Nerve Sheath Tumors (MPNST).

SARC031: A Phase 2 Trial of Selumetinib and Sirolimus for Patients with Unresectable or Metastatic Malignant Peripheral Nerve Sheath Tumors (MPNST).

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: August 01, 2025

Feasibility of Atezolizumab in Combination With Chemotherapy for Children With Relapsed or Refractory Solid Tumors.

Feasibility of Atezolizumab in Combination With Chemotherapy for Children With Relapsed or Refractory Solid Tumors.

Journal: Pediatric blood & cancer

Published: June 06, 2025

Children and Young People With First Relapse or Progression of Upfront Metastatic Rhabdomyosarcoma: An Analysis of Clinical Features and Outcomes From the INternational Soft Tissue saRcoma ConsorTium (INSTRuCT).

Children and Young People With First Relapse or Progression of Upfront Metastatic Rhabdomyosarcoma: An Analysis of Clinical Features and Outcomes From the INternational Soft Tissue saRcoma ConsorTium (INSTRuCT).

Journal: Cancer medicine

Published: May 31, 2025

Prioritization of novel agents for further investigation in pediatric non-rhabdomyosarcoma soft tissue sarcomas: A report from the Children's Oncology Group.

Prioritization of novel agents for further investigation in pediatric non-rhabdomyosarcoma soft tissue sarcomas: A report from the Children's Oncology Group.

Journal: European journal of cancer (Oxford, England : 1990)

Published: April 14, 2025

Copanlisib in combination with nivolumab formicrosatellite stable colorectal cancer: a phase 1/2 trial.

Copanlisib in combination with nivolumab formicrosatellite stable colorectal cancer: a phase 1/2 trial.

Journal: Nature communications

Published: April 01, 2025

Author Correction: Molecular profiling of 888 pediatric tumors informs future precision trials and data-sharing initiatives in pediatric cancer.

Author Correction: Molecular profiling of 888 pediatric tumors informs future precision trials and data-sharing initiatives in pediatric cancer.

Journal: Nature communications

Published: August 22, 2024

Early Detection of Malignant and Premalignant Peripheral Nerve Tumors Using Cell-Free DNA Fragmentomics.

Early Detection of Malignant and Premalignant Peripheral Nerve Tumors Using Cell-Free DNA Fragmentomics.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: March 12, 2024

Early detection of malignant and pre-malignant peripheral nerve tumors using cell-free DNA fragmentomics.

Early detection of malignant and pre-malignant peripheral nerve tumors using cell-free DNA fragmentomics.

Journal: medRxiv : the preprint server for health sciences

Published: January 31, 2024

Showing 1-12 of 32

Last Updated: 09/26/2026